Precision Biosciences Inc

DTIL NASDAQ Healthcare & Biotech United States US74019P1084
6.50 $
1.40 %

Precision Biosciences is committed to creating genetic solutions to treat human diseases and improve agriculture.

Price history of Precision Biosciences Inc
Price history of Precision Biosciences Inc

Performance & Momentum

6 Months 36.55 %
1 Year 18.40 %
3 Years 73.42 %
5 Years 98.12 %

Strategic Analysis

Precision Biosciences Inc • 2026

Precision Biosciences develops gene editing aimed at revolutionizing the treatment of human diseases and optimizing agricultural solutions. Its innovative positioning in precision biotechnology gives it a distinct technical advantage in a rapidly evolving sector.

Strengths
  • Advanced expertise in genetic engineering and genome editing
  • Disruptive potential in the healthcare and agri-food sectors
  • Presence in markets with high demand for therapeutic and agricultural innovations
Weaknesses
  • Significant long-term decline in stock performance
  • Recent lack of significant positive catalysts or news
Momentum

Current momentum is weak and reflects persistent selling pressure, mirroring market doubts about the rapid realization of projects. This context requires great caution; investors should consider this stock as speculative with a long horizon and high risk.

Similar stocks to Precision Biosciences Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone